Add to ORKGLiving-donor lobar lung transplantation seems to be best suited for children and small adults because only two lobes are transplanted. However, the amount of tolerable size discrepancy between donors and recipients is currently unknown. We report two cases of lymphangioleiomyomatosis with hyperinflation successfully treated with living-donor lobar lung transplantation in spite of large size disparity
Small-sized patients with cystic fibrosis usually face long waiting times for a suitable lung donor....
The use of lobar transplantation and other size reduction techniques has allowed larger donor lungs ...
Lymphangioleiomyomatosis is a rare pulmonary disease encountered almost exclusively in women of repr...
International audienceBackground. Lymphangioleiomyomatosis (LAM) is a rare disease, leading in some ...
ObjectiveLiving-donor lobar lung transplantation usually requires 2 healthy donors who donate either...
AbstractThe scarcity of small donors has significantly limited lung transplantation for pediatric an...
Background: Lung transplantation has been accepted widely as therapy for end-stage pulmonary lympha...
BACKGROUND: Lung transplantation has been accepted widely as therapy for end-stage pulmonary lymphan...
Lymphangioleiomyomatosis (LAM) is a rare disease in women of childbearing ages that eventually leads...
AbstractObjectiveWe report on our early experience in living-donor lobar lung transplantation for pa...
Lung transplantation (LT) usually requires an optimal donor/ recipient size matching to guarantee sa...
Lymphangioleiomyomatosis (LAM) is a rare disease that leads to airways and lymphatic channels obstru...
<div><p>Background</p><p>Lung transplantation has been established as the definitive treatment optio...
AbstractObjective: Since development of a living donor bilateral lobar transplantation protocol for ...
ObjectiveSurvival after living-donor lobar lung transplantation has been reported to be similar to t...
Small-sized patients with cystic fibrosis usually face long waiting times for a suitable lung donor....
The use of lobar transplantation and other size reduction techniques has allowed larger donor lungs ...
Lymphangioleiomyomatosis is a rare pulmonary disease encountered almost exclusively in women of repr...
International audienceBackground. Lymphangioleiomyomatosis (LAM) is a rare disease, leading in some ...
ObjectiveLiving-donor lobar lung transplantation usually requires 2 healthy donors who donate either...
AbstractThe scarcity of small donors has significantly limited lung transplantation for pediatric an...
Background: Lung transplantation has been accepted widely as therapy for end-stage pulmonary lympha...
BACKGROUND: Lung transplantation has been accepted widely as therapy for end-stage pulmonary lymphan...
Lymphangioleiomyomatosis (LAM) is a rare disease in women of childbearing ages that eventually leads...
AbstractObjectiveWe report on our early experience in living-donor lobar lung transplantation for pa...
Lung transplantation (LT) usually requires an optimal donor/ recipient size matching to guarantee sa...
Lymphangioleiomyomatosis (LAM) is a rare disease that leads to airways and lymphatic channels obstru...
<div><p>Background</p><p>Lung transplantation has been established as the definitive treatment optio...
AbstractObjective: Since development of a living donor bilateral lobar transplantation protocol for ...
ObjectiveSurvival after living-donor lobar lung transplantation has been reported to be similar to t...
Small-sized patients with cystic fibrosis usually face long waiting times for a suitable lung donor....
The use of lobar transplantation and other size reduction techniques has allowed larger donor lungs ...
Lymphangioleiomyomatosis is a rare pulmonary disease encountered almost exclusively in women of repr...